Tag : squamous-cell carcinoma

Latest News

GW expands clinical trial of neoadjuvant immunotherapy for high-risk cutaneous squamous cell carcinoma

Newsemia
The Cutaneous Oncology Program at the George Washington University (GW) Cancer Center was selected as the first global site for a clinical trial for patients...
Gastroenterology

HIMC at Mount Sinai to evaluate therapeutic effects of novel cancer immunotherapy

Newsemia
The Human Immune Monitoring Center at the Icahn School of Medicine at Mount Sinai will apply cutting-edge high-throughput technologies to evaluate the therapeutic effects of...
Latest News

Artificial intelligence helps improve diagnosis of head and neck cancers

Newsemia
Researchers from Charité – Universitätsmedizin Berlin and the German Cancer Consortium have successfully solved a longstanding problem in the diagnosis of head and neck cancers....
Latest News

Regular use of common pain relief medicines improves survival for head and neck cancer patients

Newsemia
Regular use of a common type of medication, such as aspirin and ibuprofen, significantly improves survival for a third or more patients with head and...
Latest News

Novel blood test shows promise for monitoring HPV-linked head and neck cancer after treatment

Newsemia
A new blood test developed by University of North Carolina Lineberger Comprehensive Cancer Center researchers shows promise for tracking HPV-linked head and neck cancer patients...
Latest News

New liquid biopsy test confirms remission in patients with HPV-associated oropharyngeal cancer

Newsemia
A highly sensitive blood test that detects minute traces of cancer-specific DNA has been shown to accurately determine whether patients with HPV-related oropharyngeal squamous cell...
Latest News

FDA approves first intravenous treatment for metastatic cutaneous squamous cell carcinoma

Newsemia
The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squamous cell carcinoma...
Latest News

Opdivo receives FDA approval as first Immuno-Oncology treatment option for small cell lung cancer

Newsemia
Bristol-Myers Squibb Company today announced that Opdivo received approval from the U.S. Food and Drug Administration as the first and only Immuno-Oncology treatment option for...
AI/ML

Deep convolutional neural networks for classifying head and neck cancer using hyperspectral imaging.

Newsemia
Related ArticlesDeep convolutional neural networks for classifying head and neck cancer using hyperspectral imaging. J Biomed Opt. 2017 06 01;22(6):60503 Authors: Halicek M, Lu G,...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy